FXR2 Antibodies

Santa Cruz Biotechnology provides a broad selection of FXR2 monoclonal antibodies for research focused on understanding FXR2 protein functions. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). FXR2, or Fragile X Mental Retardation 2, belongs to the fragile X family of proteins and serves essential functions in neuronal development. FXR2 regulates mRNA translation and influences various neurological processes. Research has shown FXR2's significance in cognitive development and neurological conditions. Investigating FXR2 reveals important insights about molecular mechanisms in brain function and development. Current studies continue to uncover new roles of FXR2 in neural pathways and cellular signaling. Ongoing research explores FXR2's involvement in synaptic plasticity and memory formation. Santa Cruz Biotechnology monoclonal antibodies for FXR2 support researchers worldwide in advancing neuroscience and genetic research.